At 5.2% CAGR, Asia Pacific Automated External Defibrillators Market is projected to be worth US$ 431.07 million by 2030, says Business Market Insights
According to Business Market Insights' research, the Asia Pacific automated external defibrillators market was valued at US$ 287.42 million in 2022 and is expected to reach US$ 431.07 million by 2030, registering a CAGR of 5.2% from 2022 to 2030. Increasing prevalence of cardiovascular diseases and rising training and awareness programs on automated external defibrillators are among the critical factors attributed to the Asia Pacific automated external defibrillators market expansion.
Training programs conducted by healthcare organizations, schools, workplaces, and community groups raise awareness about the signs of sudden cardiac attack (SCA), the importance of early defibrillation, and steps to take in an emergency. By promoting AED awareness and providing hands-on training, individuals are better prepared to recognize and respond to SCA incidents, potentially saving lives. Online and offline training programs by organizations such as the WHO, FDA, regional health centers, and local bodies have increased significantly across the globe. For instance, in February 2024, the Rotary Club of Bombay Airport hosted a one-of-a-kind musical spectacle called "Dil ki Batein," in which a group of medical consultants known as "Tuning Folks" entertained the audience and shared their love of singing for charity while raising awareness of cardiac arrest. The goal of this program was to gather funding and place 188 AEDs in public locations, such as 100 metro stations and 88 railroad stations. Additionally, in 2023, a three-week initiative to raise awareness about AEDs and CPR was launched by the Pune Rotary Club (India) in partnership with the Revive Heart Foundation. Also, around 300 individuals attended a free workshop at a Penang mall on AED use and CPR. The workshop, which was hosted at Queensbay Mall by the St. John Ambulance Malaysia (SJAM) northeast region, also taught parents how to perform CPR on their infants and children, including choking rescue procedures. Furthermore, Shocktober is a global campaign that raises awareness and educates the community about CPR and AEDs. This campaign was initiated in October 2020 in Australia. Therefore, rising training and awareness programs on automated external defibrillators boost the automated external defibrillator market growth.
On the contrary, performance issues related to automated external defibrillators hamper the Asia Pacific automated external defibrillators market.
Based on type, the Asia Pacific automated external defibrillators market is bifurcated into fully-automated external defibrillators and semi- automated external defibrillators. The fully-automated external defibrillators segment held 57.1% share of Asia Pacific automated external defibrillators market in 2022, amassing US$ 164.18 million. It is projected to garner US$ 240.53 million by 2030 to expand at 4.9% CAGR during 2022-2030.
Based on end user, the Asia Pacific automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. The hospitals & clinics segment held 56.6% share of Asia Pacific automated external defibrillators market in 2022, amassing US$ 162.74 million. It is projected to garner US$ 247.56 million by 2030 to expand at 5.4% CAGR during 2022-2030.
Based on country, the Asia Pacific automated external defibrillators market has been categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 31.8% share of Asia Pacific automated external defibrillators market in 2022. It was assessed at US$ 91.41 million in 2022 and is likely to hit US$ 141.78 million by 2030, exhibiting a CAGR of 5.6% during 2022-2030.
Key players operating in the Asia Pacific automated external defibrillators market are Asahi Kasei Corp, BPL Medical Technologies Pvt Ltd, CU Medical Systems Inc, Koninklijke Philips NV, Mediana Co Ltd, Nihon Kohden Corp, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Stryker Corp, among others.
In May 2023, Shenzhen Mindray Bio-Medical Electronics Co Ltd had signed a strategic agreement with Vithas. Under the agreement, Vithas integrated the latest innovative patient monitoring technology across its 20 hospitals. The strategic partnership enabled Vithas to improve patient safety in critical areas like ICU, operating rooms, post-anesthesia recovery, and emergencies.
In September 2022, BPL had inaugurated the second manufacturing facility. Located in Bangalore, this facility comprised about 80,000 sq ft of manufacturing and assembly area.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
